Interaction of epithelial biomarkers, local immune response and condom use in cervical intraepithelial neoplasia 2-3 regression

Gynecologic Oncology

Volumn 127, Issue 3, 2012, Pages 489-494

  Munk, Ane Cecilie ^a   Gudlaugsson, Einar ^a   Ovestad, Irene Tveiteras ^a   Lovslett, Kjell ^a   Fiane, Bent ^a   Hidle, Bianca Van Diermen ^a   Kruse, Arnold Jan ^b   Skaland, Ivar ^a   Janssen, Emiel A M ^a   Baak, Jan P A ^a  

^a STAVANGER UNIVERSITY HOSPITAL   (Norway)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

CD4; Cervical intraepithelial neoplasia; CIN length; Condom use; pRb; Regression

Indexed keywords

BIOLOGICAL MARKER;

ADULT; ARTICLE; BASEMENT MEMBRANE; CANCER REGRESSION; CANCER SIZE; CD4+ T LYMPHOCYTE; COLPOSCOPY; CONDOM; FEMALE; HUMAN; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; LYMPHOID CELL; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; STROMA; TUMOR BIOPSY; UTERINE CERVIX CARCINOMA IN SITU;

ADULT; BIOLOGICAL MARKERS; CD4 LYMPHOCYTE COUNT; CERVICAL INTRAEPITHELIAL NEOPLASIA; COHORT STUDIES; CONDOMS; FEMALE; HUMANS; PAPILLOMAVIRIDAE; PROSPECTIVE STUDIES; UTERINE CERVICAL NEOPLASMS;

EID: 84868533854     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2012.09.010     Document Type: Article

References (36)

1. F. Coutlee, S. Ratnam, and A.V. Ramanakumar Distribution of human papillomavirus genotypes in cervical intraepithelial neoplasia and invasive cervical cancer in Canada J Med Virol 83 2011 1034 1041
2. J.M. Walboomers, M.V. Jacobs, and M.M. Manos Human papillomavirus is a necessary cause of invasive cervical cancer worldwide J Pathol 189 1999 12 19
3. A.G. Ostor Natural history of cervical intraepithelial neoplasia: a critical review Int J Gynecol Pathol 12 1993 186 192
4. K. Nasiell, M. Nasiell, and V. Vaclavinkova Behavior of moderate cervical dysplasia during long-term follow-up Obstet Gynecol 61 1983 609 614
5. J.P. Baak, A.J. Kruse, and S.J. Robboy Dynamic behavioural interpretation of cervical intraepithelial neoplasia with molecular biomarkers J Clin Pathol 59 2006 1017 1028
6. I.T. Ovestad, E. Gudlaugsson, and I. Skaland Local immune response in the microenvironment of CIN2-3 with and without spontaneous regression Mod Pathol 23 2010 1231 1240
7. M.R. McCredie, K.J. Sharples, and C. Paul Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study Lancet Oncol 9 2008 425 434
8. C.L. Trimble, S. Piantadosi, and P. Gravitt Spontaneous regression of high-grade cervical dysplasia: effects of human papillomavirus type and HLA phenotype Clin Cancer Res 11 2005 4717 4723
9. S.S. Barken, M. Rebolj, E.S. Andersen, and E. Lynge Frequency of cervical intraepithelial neoplasia treatment in a well-screened population Int J Cancer 130 2012 2438 2444
10. B. Hagen, F.E. Skjeldestad, and H. Bratt CO2 laser conization for cervical intraepithelial neoplasia grade II-III: complications and efficacy Acta Obstet Gynecol Scand 77 1998 558 563
11. M. Kyrgiou, G. Koliopoulos, and P. Martin-Hirsch Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and meta-analysis Lancet 367 2006 489 498
12. S. Albrechtsen, S. Rasmussen, and S. Thoresen Pregnancy outcome in women before and after cervical conisation: population based cohort study BMJ 337 2008 a1343
13. A.C. Munk, A.J. Kruse, and B. van Diermen Cervical intraepithelial neoplasia grade 3 lesions can regress APMIS 115 2007 1409 1414
14. M. Scheffner, B.A. Werness, and J.M. Huibregtse The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53 Cell 63 1990 1129 1136
15. N. Dyson, P.M. Howley, K. Munger, and E. Harlow The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product Science 243 1989 934 937
16. G.D. Zielinski, P.J. Snijders, and L. Rozendaal The presence of high-risk HPV combined with specific p53 and p16INK4a expression patterns points to high-risk HPV as the main causative agent for adenocarcinoma in situ and adenocarcinoma of the cervix J Pathol 201 2003 535 543
17. J.P. Baak, A.J. Kruse, and S.M. Garland Combined p53 and retinoblastoma protein detection identifies persistent and regressive cervical high-grade squamous intraepithelial lesions Am J Surg Pathol 29 2005 1062 1066
18. A.M. Kersemaekers, G.J. Fleuren, and G.G. Kenter Oncogene alterations in carcinomas of the uterine cervix: overexpression of the epidermal growth factor receptor is associated with poor prognosis Clin Cancer Res 5 1999 577 586
19. K. Matsuda, S. Miura, and T. Kurashige Significance of p53-binding protein 1 nuclear foci in uterine cervical lesions: endogenous DNA double strand breaks and genomic instability during carcinogenesis Histopathology 59 2011 441 451
20. G. Roncador, P.J. Brown, and L. Maestre Analysis of FOXP3 protein expression in human CD4+CD25 + regulatory T cells at the single-cell level Eur J Immunol 35 2005 1681 1691
21. T.A. Waldmann The multi-subunit interleukin-2 receptor Annu Rev Biochem 58 1989 875 911
22. I.T. Ovestad, E. Gudlaugsson, and I. Skaland The impact of epithelial biomarkers, local immune response and human papillomavirus genotype in the regression of cervical intraepithelial neoplasia grades 2-3 J Clin Pathol 64 2011 303 307
23. P. Holowaty, A.B. Miller, T. Rohan, and T. To Natural history of dysplasia of the uterine cervix J Natl Cancer Inst 91 1999 252 258
24. C.J. Hogewoning, M.C. Bleeker, and A.J. van den Brule Condom use promotes regression of cervical intraepithelial neoplasia and clearance of human papillomavirus: a randomized clinical trial Int J Cancer 107 2003 811 816
25. A.J. Kruse, J.P. Baak, and P.C. de Bruin Ki-67 immunoquantitation in cervical intraepithelial neoplasia (CIN): a sensitive marker for grading J Pathol 193 2001 48 54
26. K. Soreide Receiver-operating characteristic curve analysis in diagnostic, prognostic and predictive biomarker research J Clin Pathol 62 2009 1 5
27. R.J. Gornall, I.E. Boyd, T. Manolitsas, and A. Herbert Interval cervical cancer following treatment for cervical intraepithelial neoplasia Int J Gynecol Cancer 10 2000 198 202
28. A.C. Richardson, and J.B. Lyon The effect of condom use on squamous cell cervical intraepithelial neoplasia Am J Obstet Gynecol 140 1981 909 913
29. A. Kobayashi, V. Weinberg, T. Darragh, and K. Smith-McCune Evolving immunosuppressive microenvironment during human cervical carcinogenesis Mucosal Immunol 1 2008 412 420
30. G. Bottley, O.G. Watherston, and Y.L. Hiew High-risk human papillomavirus E7 expression reduces cell-surface MHC class I molecules and increases susceptibility to natural killer cells Oncogene 27 2008 1794 1799
31. K.E. de Visser, A. Eichten, and L.M. Coussens Paradoxical roles of the immune system during cancer development Nat Rev Cancer 6 2006 24 37
32. V. Kataja, K. Syrjanen, and R. Mantyjarvi Prospective follow-up of cervical HPV infections: life table analysis of histopathological, cytological and colposcopic data Eur J Epidemiol 5 1989 1 7
33. P. Halfon, E. Trepo, and G. Antoniotti Prospective evaluation of the Hybrid Capture 2 and AMPLICOR human papillomavirus (HPV) tests for detection of 13 high-risk HPV genotypes in atypical squamous cells of uncertain significance J Clin Microbiol 45 2007 313 316
34. F. Carozzi, S. Bisanzi, and C. Sani Agreement between the AMPLICOR Human Papillomavirus Test and the Hybrid Capture 2 assay in detection of high-risk human papillomavirus and diagnosis of biopsy-confirmed high-grade cervical disease J Clin Microbiol 45 2007 364 369
35. I.T. Ovestad, U. Vennestrom, and L. Andersen Comparison of different commercial methods for HPV detection in follow-up cytology after ASCUS/LSIL, prediction of CIN2-3 in follow up biopsies and spontaneous regression of CIN2-3 Gynecol Oncol 123 2011 278 283
36. S. Hariri, M. Steinau, and A. Rinas HPV genotypes in high grade cervical lesions and invasive cervical carcinoma as detected by two commercial DNA assays, North Carolina, 2001-2006 PLoS One 7 2012 e34044